Rheumatology:
the immunologist’s craft

At a glance

Every specialty on this site involves a trade, and rheumatology’s points two directions at once. You give up procedural income and accept a genuinely competitive Match, and in return you get some of the most cognitively rich chronic-disease medicine in internal medicine, one of the most controllable lifestyles in the field, and near-total job security in a specialty the country cannot staff. It is in short supply not because nobody wants it, but because the pipeline is small, the pay lags the procedural fields, and the graduates it does produce cluster in cities. That shapes every section below.

What it involves

Rheumatology is the medicine of systemic autoimmune and inflammatory disease and of musculoskeletal disorders: rheumatoid arthritis, systemic lupus erythematosus, the spondyloarthropathies, the vasculitides, Sjögren’s syndrome, systemic sclerosis, the inflammatory myopathies, crystal-induced arthritis (gout and CPPD), osteoarthritis, metabolic bone disease, the autoinflammatory syndromes, fibromyalgia, and the wide band of overlap and undifferentiated connective-tissue disease. Because these illnesses are chronic, systemic, and multi-organ, rheumatology is longitudinal and relationship-centered — rheumatologists follow patients for years and often decades, titrating immunosuppression and watching for both disease activity and drug toxicity. The therapeutic side is demanding: conventional DMARDs, biologics targeting TNF, IL-6, IL-17, IL-23, and B cells, and the JAK inhibitors, all balanced against infection and malignancy risk.

The training pathway and the procedures

After a three-year IM residency and ABIM internal medicine certification, adult rheumatology fellowship is 24 months of ACGME-accredited training, at least 12 clinical, with a continuity ambulatory clinic running throughout, alongside inpatient and outpatient consultation⁵⁶. On procedures, be precise: fellows must become competent in arthrocentesis of peripheral joints and periarticular/soft-tissue injections and in synovial-fluid analysis under polarized light — these are routine, daily-practice skills, not a rarity. Musculoskeletal ultrasound appears in the requirements only at the level of knowing indications and interpretation, not as a required hands-on performance skill; MSK ultrasound as a procedural competency is a growing but elective add-on (see Intellectual scope)⁵. Pediatric rheumatology is a separate pathway certified by the American Board of Pediatrics, entered after a pediatrics residency; med-peds graduates can pursue either adult (ABIM) or pediatric (ABP) rheumatology, and a combined rheumatology–allergy/immunology pathway also exists.

Sub-tracks and niches — and where they live

Most niches are built within the standard two years and deepened on the job. One thing to understand early: the disease-focused academic niches concentrate at referral centers, while general community rheumatology is what most of the country actually needs (which matters for the geography discussion later).

Competitiveness

Here is the fact that surprises people: rheumatology is competitive. It is not a procedural bloodbath like cardiology or gastroenterology, but it fills nearly every seat and turns away a real share of the residents who want it. In the 2026 appointment-year Match, adult rheumatology offered 302 certified positions across 133 programs and filled 299 (99.0%); of 371 applicants who preferred it, 295 (79.5%) matched, and 71 (19.1%) did not match to any program¹. That roughly one-in-five failure-to-match rate, in a field that fills essentially all its seats, is the honest measure of the competition.

Why is a two-year, lower-paid, largely non-procedural field this hard to get into? Because its appeal is real and its supply is small: a controllable lifestyle, rich cognitive content, and a therapeutic revolution, against a seat count that has grown only slowly. As with endocrinology, the most sought-after academic programs often favor their own residents, so a solid resident who genuinely wants rheumatology can very likely match — but not automatically, and not everywhere.

An applicant roadmap. Because the field rewards demonstrated, specific commitment, prepare early:

1. PGY-1: get a rheumatology elective early, find a faculty mentor, and get involved with the ACR; most successful applicants decide during residency.
2. PGY-2: turn interest into evidence — a case report, abstract, or QI project; complete Step 3; secure advocacy-grade rheumatology-faculty letters alongside your program director’s.
3. PGY-3 (application year): apply broadly, use your program signals to reinforce genuine interest, and build a deliberate geographic strategy, since programs weight fit and ties.

Program directors reward a coherent, believable commitment to the specialty over generic “lifestyle” motivation. Rheumatology participates in ERAS program signaling, but the number of signals and tier rules change from cycle to cycle — verify the current allotment before you apply⁸.

Skills & personality

Rheumatology rewards a specific temperament. The first requirement is a tolerance for diagnostic ambiguity: much of the work is assembling incomplete, conflicting data — a rash, a fatigue, a borderline antibody — into a coherent picture over time. People who need quick, binary closure tend to be frustrated; people who enjoy the puzzle thrive. The second is a genuinely cognitive orientation: this is a thinking specialty built on immunology, physiology, and pharmacology, and its satisfactions are intellectual rather than procedural.

Beyond that, the field asks for comfort with chronic disease and longitudinal relationships, because rheumatologists rarely “cure” — they manage, and the reward is watching patients regain function over years. It asks for real communication skill; systems thinking and collaboration, because multi-organ disease means coordinating with nephrology, pulmonology, dermatology, and ophthalmology; and meticulous risk management, because immunosuppressive regimens demand vigilant monitoring for toxicity, infection, and drug interactions.

Who tends to be unhappy? Physicians who crave procedures, acuity, and immediate hands-on fixes; those impatient with slow diagnostic and therapeutic timelines; those motivated primarily by top-tier compensation; and — candidly — anyone with no patience for the prior-authorization and payer bureaucracy that surrounds modern immunosuppression. The paycheck and the paperwork will not carry someone who does not love the content.

Lifestyle & balance

Rheumatology is widely regarded as one of the most lifestyle-friendly paths in internal medicine, and that reputation is a major driver of its competitiveness. The work is predominantly weekday outpatient clinic — cognitively demanding but predictable, not shift-based. Inpatient consultative work exists, often shared among partners or faculty, but overnight and weekend burden is modest compared with cardiology, GI, or pulmonary and critical care, and the procedural load is elective in its timing: joint and bursa aspiration and injection, and, for those trained in it, point-of-care ultrasound. There are no emergent procedures. The outpatient nature also supports part-time work, predictable family time, and telehealth.

Now the honest counterweight, the same one that runs through every cognitive field on this site: a friendly clock has not protected rheumatologists from burnout, and the driver is not hours — it is administrative burden. Prior authorizations for expensive biologics, step-therapy hurdles, documentation, and payer friction are consistently named as the frustrations of the specialty, and burnout reporting places the field in the same range as much busier specialties⁹. The clock is friendly; the bureaucracy is not.

Compensation & infusion economics

State the paradox plainly: rheumatology sits toward the lower end of internal-medicine subspecialty pay despite obvious and worsening demand. In the Doximity 2025 report (2024 earnings), adult rheumatology’s average total compensation was $324,954, and pediatric rheumatology $231,574²; Medscape likewise places adult rheumatology in the lower tier year after year⁹. The pay lags the procedural specialties. Why the low pay despite the shortage? Because fee-for-service reimbursement rewards procedures and volume, not cognitive complexity: rheumatology income comes largely from evaluation-and-management billing — long, demanding visits still coded as office visits — and the field performs few high-RVU procedures.

The one meaningful lever that can move the number is practice-model-dependent: in-office infusion suites for intravenous biologics. But it deserves its operational and ethical context, not just a mention:

• Ownership versus employment. The infusion margin accrues to whoever owns the suite — a private or community practice can capture drug-margin (“buy-and-bill”) and infusion-administration revenue; an employed rheumatologist in a system that owns the suite generally does not.
• Buy-and-bill risk. The practice purchases expensive biologics up front and is reimbursed at a margin, so it carries inventory and price risk, and the margins are thin — average-sales-price pricing and specialty-pharmacy / “white-bagging” models (where the payer supplies the drug) can remove the margin entirely.
• Staffing and payer exposure. An infusion suite needs infusion nurses, chair time, scheduling, and prior-authorization staff; denials and step-therapy requirements can strand a scheduled infusion.
• Keep the clinical decision independent. When practice revenue depends on infused drugs, there is a built-in incentive toward IV over equally effective subcutaneous or oral options; sound practice keeps the choice of agent and route tied to the evidence and the patient, not the margin.

Joint injections, MSK ultrasound, DXA, and lab ancillaries supplement pay more modestly. Geography works in the direction you might not expect: rural and underserved markets, which need rheumatologists most, tend to offer the strongest recruitment packages, signing bonuses, and loan-repayment incentives, while saturated coastal metros pay less.

Intellectual scope

If the paycheck is the field’s weakness, the intellectual life is its draw. Rheumatology is diagnostic reasoning at its purest: presentations are ambiguous, the serologies are suggestive rather than definitive, and the physician earns the diagnosis by integrating history, examination, immunology, and imaging — then manages it with a pharmacology few other specialists command. Because autoimmunity touches every organ, the differential is broad, and the same clinic day can move from a straightforward gout flare to a new multisystem lupus to an undifferentiated connective-tissue disease that resolves only with time.

The field also moves fast — biologics against an expanding set of targets, the JAK inhibitors, and emerging cell therapies including CAR-T approaches for refractory autoimmune disease make it a fertile research field. And there is one genuinely distinctive procedural frontier worth understanding honestly: musculoskeletal ultrasound, which detects synovitis, erosions, tenosynovitis, enthesitis, and crystal deposits and guides aspirations and injections. But the surrounding facts are mixed: the ACR’s RhMSUS certification is currently paused while the college evaluates its future, so the credential itself is in flux, and training now runs largely through external pathways such as USSONAR¹⁰⁷. And in a survey of USSONAR-trained US rheumatologists, most were certified and performed both diagnostic and procedural ultrasound — yet many did not bill for much of it, citing insufficient documentation time and poor reimbursement¹¹. MSK ultrasound is a genuine skill worth acquiring; just enter it with clear eyes about the credentialing and billing realities.

Pathways & career arc

Employed health-system and community practice is a common destination, generally paying more than academia and carrying less business overhead than private practice. Private practice offers the most autonomy and the highest earning potential where infusion suites and ancillaries are integrated, at the cost of real administrative and business responsibility. Academic practice trades cash for teaching, research, protected time, and complex referral disease. Beyond the clinic, rheumatology opens unusually good non-clinical doors, because it is a drug-development-rich field: pharma and biotech medical affairs and clinical development, telehealth, informatics, administration, and consulting.

The workforce picture is the defining feature of the field, and it is unusually well documented — but read the horizon years, because these are projections, not measurements:

• The 2015 ACR Workforce Study projected adult clinical supply falling from 5,415 clinical FTE (2015) to about 4,051 by 2030 (a 25.2% decline), with 2030 demand exceeding supply by roughly 102%³.
• A 2024 Medicare-data analysis found the workforce had actually grown modestly — rheumatologists up about 23% from 2009 to 2020, advanced-practice providers up about 141% — and yet 72% of US counties had no clinically active rheumatologist (93% of rural counties, 48% of urban)¹².
• A 2026 microsimulation projected that by 2037 nonmetropolitan rheumatology adequacy would reach just 18.5% — against 97.3% in metropolitan areas — with the lowest-adequacy states led by Idaho at 14.3%⁴.

Shortage does not mean geographic freedom in every niche. The demand is real and nearly universal — but it is demand for general rheumatology. The disease-focused subspecialty niches (vasculitis, lupus/CTD, scleroderma-ILD, myositis, MSKUS-heavy or infusion-ownership practice) concentrate in metros and academic centers. Practicing rural rheumatology usually means practicing broad general rheumatology, often as the only rheumatologist for a wide catchment, comfortable without on-site subspecialty backup and leaning on telehealth and travel. If you want both a specific academic niche and a rural life, know that those two goals can pull against each other. The peer-reviewed wait-time literature underscores the access gap: an Ontario study found a median wait of 74 days from referral to a rheumatologist — a labeled non-US comparator, with the US shortage documented directly by the workforce studies above¹³.

The career arc, honestly. Rheumatology is one of the more durable and sustainable careers in medicine — cognitive, outpatient, not physically strenuous, and easy to scale to part-time or telehealth as life changes. Niches can be added over time (MSKUS, a disease focus, infusion oversight), and the drug-development-rich science makes an industry or medical-affairs second act unusually accessible. Job security is excellent throughout — within a compensation band the payment system, not scarcity, sets.

Choosing a fellowship & first job

Rheumatology asks you to choose twice: first a fellowship, then a first job. The through-line is the same: decide what matters for your direction, evaluate the program or group against it, and negotiate the terms.

Choosing the fellowship. Weigh clinical breadth, disease-focus and MSK-ultrasound exposure if those draw you, research support for an academic path, geography, and — for IMGs — documented visa sponsorship (below). Because top academic programs favor their own residents, apply realistically and let signals reinforce genuine fit.

Choosing the first job. Normalize competing offers to the same terms and get the details in writing:

• The clinical model: clinic volume and new-versus-follow-up mix, inpatient-consult share and call, and the inbox and prior-authorization support that makes a cognitive, biologic-heavy practice livable.
• The economics: base versus productivity, and — if an infusion suite is involved — whether and how you participate in its revenue, plus the operational realities above (staffing, white-bagging, denials).
• The contract: non-compete scope, without-cause termination, malpractice and tail, and who employs you; loan-repayment and sign-on incentives are strongest in the underserved markets that also pay the most.

IMG considerations

If you are an international medical graduate, rheumatology is one of the fields where IMGs are not on the margin — they are central to the workforce. In the 2026 appointment-year Match, the matched adult-rheumatology class was 34.8% US MD, 16.4% DO, 35.5% non-US-citizen IMG, and 13.4% US-citizen IMG — IMGs made up roughly half (48.8%) of the matched class¹. The peer-reviewed literature puts it squarely: a 2023 call to action notes that at least 35% of active rheumatologists and 37% of matched applicants are IMGs, and over 80% of IMGs plan to practice in the US¹⁴. IMGs help hold this specialty together. (Two companion analyses take up the wider questions: whether international graduates take US graduates' spots, and the H-1B for physicians in training; practical planning lives on the IMG guide.)

Frame the opportunity honestly, though, because rheumatology differs from the low-fill fields on this site. Infectious disease and geriatrics are wide open; rheumatology is not — it fills essentially every seat and turns away roughly one in five of its own applicants, so an IMG needs to be a genuinely strong, committed candidate. This is a welcoming field for IMGs, but not a fallback door.

On visas, keep the two stages separate. For training, programs commonly sponsor J-1 through ECFMG’s Exchange Visitor Sponsorship Program, while H-1B sponsorship exists but varies by institution — ask each program early¹⁵. One rheumatology-specific research barrier: NIH institutional and individual training grants (T and K series) require US citizenship or permanent residency, so non-citizen IMGs are effectively ineligible for those grant-funded slots and may be steered toward clinical rather than grant-supported research years¹⁴. For employment after training, the shortage geography works in an IMG’s favor: because the deepest need is rural and nonmetropolitan, a J-1 physician can often line up a Conrad 30 or other underserved-service waiver with a job in exactly those markets — but the waiver is not automatic; the employer must place you in a designated shortage area and sponsor it, and the eligible location must be verified¹⁶.

Eligibility follows the standard package: a valid ECFMG certificate, completion of a US ACGME-accredited IM residency, ABIM internal medicine certification, and letters including your program director’s. For an IM-bound IMG who loves immunology and diagnostic reasoning and is willing to serve where the need is greatest, rheumatology is one of the most natural fits in internal medicine — provided you bring a competitive application.

Bottom line

Consider rheumatology if you love diagnostic reasoning, immunology, and pharmacology, and find satisfaction in managing multisystem chronic disease over years; you want longitudinal, relationship-centered care rather than one-off procedures or acute rescues; you value a controllable, predominantly outpatient life with light call; you want near-total job security and real geographic choice, and are open to the underserved markets where demand and incentives are highest; or you are an IMG seeking a welcoming, shortage-driven subspecialty and can bring a competitive application.

It may not fit if you are motivated primarily by top-tier compensation, or want a heavy procedural, high-acuity practice; if you need quick diagnostic and therapeutic closure and find ambiguity or slow-acting therapies frustrating; if you have little tolerance for prior-authorization and payer burden, a leading driver of dissatisfaction; or if you want to skip a competitive application, because rheumatology turns away a meaningful share of the residents who prefer it.

A last mentor’s note: rheumatology is the rare specialty where the country’s need and the individual’s quality of life point the same way — a field short of physicians, gentle to live in, and intellectually deep, whose main costs are a competitive door and a paycheck that trails the proceduralists. The people who choose it tend to talk about the work. Find a rheumatologist at your program, spend a day in clinic, and ask why they chose it. If the reasoning lights you up the way the diagnosis lights them up, you have likely found your field.

References

1. National Resident Matching Program. (2025). Results and data: Specialties Matching Service — Match Results Statistics, Medicine and Pediatric Specialties, 2026 appointment year. https://www.nrmp.org/match-data/ Adult rheumatology: 302 certified positions across 133 programs, 299 filled (99.0%). Of 371 applicants preferring it, 295 (79.5%) matched into it, 5 (1.3%) into another specialty, 71 (19.1%) unmatched. Matched class: 34.8% US MD, 16.4% DO, 35.5% non-US-citizen IMG, 13.4% US-citizen IMG (IMGs ~48.8%). ↩₁ ↩₂ ↩₃
2. Doximity. (2025). Physician compensation report 2025 (2024 data). https://www.doximity.com/reports/physician-compensation-report/2025 Self-reported/modeled survey. Adult rheumatology average about $324,954; pediatric rheumatology about $231,574. ↩₁ ↩₂
3. Battafarano, D. F., et al. (2018). 2015 American College of Rheumatology workforce study: Supply and demand projections of adult rheumatology workforce, 2015–2030. Arthritis Care & Research. https://pubmed.ncbi.nlm.nih.gov/29400009/ Projected adult clinical supply falling from 5,415 clinical FTE (2015) to about 4,051 by 2030 (a 25.2% decline), with 2030 demand exceeding supply by 4,133 clinical FTE (~102%). Model-based projection, horizon 2030. ↩₁ ↩₂
4. Silvestre, J., et al. (2026). Rheumatology workforce microsimulation to 2037. Arthritis Care & Research. https://doi.org/10.1002/acr.80092 HRSA Health Workforce Simulation Model: by 2037, nonmetropolitan rheumatology adequacy projected at 18.5% versus 97.3% metropolitan; lowest-adequacy states led by Idaho at 14.3%. Model-based projection, horizon 2037. ↩₁ ↩₂
5. Accreditation Council for Graduate Medical Education. (2025). Program requirements for graduate medical education in rheumatology. https://www.acgme.org/globalassets/pfassets/programrequirements/2025-reformatted-requirements/150_rheumatology_2025_reformatted.pdf 24-month fellowship, at least 12 clinical months, continuity clinic throughout. Required procedural competence: arthrocentesis of peripheral joints, periarticular/soft-tissue injections, and synovial-fluid analysis under polarized light. Musculoskeletal ultrasound appears at the level of knowing indications and interpretation, not as a required hands-on performance skill. ↩₁ ↩₂
6. American Board of Internal Medicine. (n.d.). Rheumatology certification policies. https://www.abim.org/certification/policies/internal-medicine-subspecialty-policies/rheumatology/ The Review Committee accepts current ABIM or AOBIM certification in rheumatology. ↩
7. Ultrasound School of North American Rheumatologists. (n.d.). Training program. https://www.ussonar.org/training-program ↩₁ ↩₂
8. Association of American Medical Colleges. (2025). Applying to fellowships with ERAS and program signaling. https://students-residents.aamc.org/applying-fellowships-eras/apply-fellowships-eras-system Rheumatology participates in ERAS program signaling; signal counts and tier rules change from cycle to cycle — verify the current allotment before applying. ↩
9. Medscape. (2025). Rheumatologist compensation and lifestyle/burnout reports. Self-reported survey; subscription access required, not reproduced here. Places adult rheumatology in the lower tier of specialty pay year after year, and reports its burnout in the range of much busier specialties. ↩₁ ↩₂
10. American College of Rheumatology. (2026). RhMSUS certification. https://rheumatology.org/rhmsus-certification Per the ACR, the RhMSUS certification program is currently paused while the college evaluates its future. No end date is stated. ↩
11. Nishio, M., Torralba, K. D., Ziniel, S. I., et al. (2024). Musculoskeletal ultrasound practices of graduates of a blended-learning program. Arthritis Care & Research. https://doi.org/10.1002/acr.25470 Survey of USSONAR-trained US rheumatologists: most were certified and performed both diagnostic and procedural ultrasound, yet many did not bill for much of it, citing insufficient documentation time and poor reimbursement. ↩
12. Mannion, M. L., et al. (2024). Changes in the workforce characteristics of providers who care for adult patients with rheumatologic and musculoskeletal disease in the United States. Arthritis & Rheumatology. https://pubmed.ncbi.nlm.nih.gov/38403436/ Medicare data, 2006–2020: rheumatologists rose about 23% (2009–2020) and advanced-practice providers about 141%, yet 72% of US counties had no clinically active rheumatologist (93% of rural, 48% of urban). ↩
13. Widdifield, J., et al. (2016). Wait times to rheumatology care. CMAJ Open. https://pmc.ncbi.nlm.nih.gov/articles/PMC4933643/ Ontario, Canada: median wait of 74 days from referral to a rheumatologist, beyond recommended benchmarks. A labeled non-US comparator; US waits are documented directly by the workforce studies above. ↩
14. Fernandez-Ruiz, R., et al. (2023). Supporting international medical graduates in rheumatology: A call to action. Arthritis & Rheumatology. https://pmc.ncbi.nlm.nih.gov/articles/PMC9892202/ At least 35% of active rheumatologists and 37% of matched rheumatology fellowship applicants are IMGs; over 80% of IMGs plan to practice in the US. NIH institutional and individual training grants (T and K series) require US citizenship or permanent residency, effectively excluding non-citizen IMGs from those grant-funded slots. ↩₁ ↩₂
15. Educational Commission for Foreign Medical Graduates. (n.d.). Exchange Visitor Sponsorship Program (J-1): General information. https://www.ecfmg.org/evsp/applying-general.html ↩
16. U.S. Citizenship and Immigration Services. (n.d.). Conrad 30 Waiver Program. https://www.uscis.gov/working-in-the-united-states/students-and-exchange-visitors/conrad-30-waiver-program J-1 waiver requires placement in a designated shortage area and employer sponsorship; the eligible job location must be verified. ↩
17. Restriction on Entry of Certain Nonimmigrant Workers, Proclamation No. 10973. (2025, September 24). Federal Register. https://www.federalregister.gov/documents/2025/09/24/2025-18601/restriction-on-entry-of-certain-nonimmigrant-workers Signed September 19, 2025; effective September 21, 2025. Imposes a $100,000 payment requirement on certain new H-1B petitions for beneficiaries outside the United States, with national-interest exemptions and a twelve-month sunset absent extension. ↩
18. U.S. Citizenship and Immigration Services. (2025). H-1B: Frequently asked questions on the September 2025 proclamation. https://www.uscis.gov/newsroom/alerts/h-1b-faq USCIS guidance that the payment requirement applies to new petitions for beneficiaries outside the United States without a valid H-1B visa, and does not reach previously issued visas, earlier-filed petitions, renewals, or change-of-status, amendment, and extension petitions for people already in the country. ↩
19. State of California v. Mullin, No. 1:25-cv-13829-LTS (D. Mass. June 8, 2026) (Sorokin, J.), appeal docketed, No. 26-01699 (1st Cir. 2026). https://www.fragomen.com/insights/united-states-district-court-temporarily-stays-order-vacating-dollar100000-h-1b-fee.html The district court vacated the payment requirement on June 8, 2026 as an unlawful tax and Administrative Procedure Act violation, then temporarily stayed its own order on June 12, 2026 pending appeal; the government appealed to the First Circuit. The requirement therefore remains operational for affected petitions at this writing. A fast-moving matter — verify current status before relying. ↩

Figures here are survey-, model-, and projection-based and shift year to year; compensation surveys differ in method, are read directionally, and several are subscription-gated; the workforce numbers are model-based projections tied to the horizon years stated; and the immigration landscape is in active flux. Verify against the primary source before relying on any single figure for a career, contract, or immigration decision. This page is educational and is not career, financial, immigration, or legal advice.